Basel Medical Group Ltd Ordinary Shares (BMGL) — Defensive Interval Ratio
Basel Medical Group Ltd Ordinary Shares (BMGL) has a Defensive Interval Ratio of 85 days as of September 2025. Defensive assets of $2.49 Million (cash $-, short-term investments $-, receivables $2.49 Million) cover 85 days of daily cash needs of $29.29K/day. See Basel Medical Group Ltd Ordinary Shares (BMGL) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Basel Medical Group Ltd Ordinary Shares Defensive Interval Ratio (2022–2025)
This chart shows how Basel Medical Group Ltd Ordinary Shares's Defensive Interval Ratio has evolved across 4 annual periods from 2022 to 2025. As of September 2025, the ratio stands at 85 days, meaning defensive assets of $2.49 Million can fund 85 days of operations without new revenue. See how leveraged is Basel Medical Group Ltd Ordinary Shares's balance sheet to measure how much of total assets are equity-financed.
Annual Defensive Interval Ratio for Basel Medical Group Ltd Ordinary Shares (2022–2025)
The table below presents the year-by-year Defensive Interval Ratio for Basel Medical Group Ltd Ordinary Shares from 2022 to 2025, covering 4 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see BMGL market cap overview.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2025 | 85 days | $2.49 Million | $29.29K/day | $- | $- | ▼ -549 days |
| 2024 | 634 days | $12.44 Million | $19.63K/day | $- | $- | ▼ -118 days |
| 2023 | 752 days | $13.33 Million | $17.72K/day | $- | $- | ▲ +48 days |
| 2022 | 705 days | $13.88 Million | $19.71K/day | $- | $- | — |